Company: OSRH
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076461
Chunk: 163

Company: OSR Holdings, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 1A
Chunk 163
---
Item 1A. Risk Factors

In addition to the risk factors set forth below and
the other information set forth in this report, you should carefully consider the factors discussed under Part I, Item 1A, “Risk
Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on April 22,
2025 (or “2025 Annual Report”), and in the other reports we file with the SEC before making a decision to invest in our securities.
These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position,
and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking
statements contained in this report or we could face liquidation. In that event, the trading price of our securities could decline, and
you could lose all or part of your investment. The risks and uncertainties described in our 2024 Annual Report and below are not the
only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also
become important factors that adversely affect our business, financial condition and operating results. Except as disclosed below, there
have been no material changes to the risk factors described in Part I, Item 1A, “Risk Factors,” included in our 2025 Annual
Report.

Item 2. Unregistered Sales of
Equity Securities and Use of Proceeds

Pursuant to the terms of an Equity Line of Credit Agreement comprising
a Common Stock Purchase Agreement and a Registration Rights Agreement (taken together, the “ELOC Agreement”) as amended May
6, 2025, the Company may elect, in our sole discretion, to issue and sell to by White Lion Capital LLC dba White Lion GBM Innovation
Fund (“White Lion”), from time to time, up to $78.9 million worth of shares of Common Stock from after the effective date
of a related registration statement until the earlier of December 31, 2026 or the sale of all of such shares to White Lion. Any terms
in initial capitals and not otherwise defined herein shall be as defined in the amended Common Stock Purchase Agreement and/or the Registration
Rights Agreement.

Pursuant to the Common Stock Purchase Agreement, following the effective
date of this resale registration statement registering the shares issuable to White Lion in accordance with the terms of the Registration
Rights Agreement